Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-25-025650
Filing Date
2025-07-11
Accepted
2025-07-11 16:06:44
Documents
25
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20044912x1_pre14a.htm   iXBRL PRE 14A 1073791
4 GRAPHIC logo_plustherapeutics.jpg GRAPHIC 33525
5 GRAPHIC logo_plustherapeuticsx1.jpg GRAPHIC 42581
6 GRAPHIC ny20044912x1_chair.jpg GRAPHIC 4707
7 GRAPHIC ny20044912x1_expert.jpg GRAPHIC 4309
8 GRAPHIC ny20044912x1_member.jpg GRAPHIC 4238
9 GRAPHIC ny20044912x1_pc01.jpg GRAPHIC 729334
10 GRAPHIC ny20044912x1_pc02.jpg GRAPHIC 671037
11 GRAPHIC ny20044912x1_pvpchart01x1.jpg GRAPHIC 160752
12 GRAPHIC ny20044912x1_pvpchart02x1.jpg GRAPHIC 185777
13 GRAPHIC sig_marchedrick.jpg GRAPHIC 21627
14 GRAPHIC sig_marchedrickx1.jpg GRAPHIC 28584
  Complete submission text file 0001140361-25-025650.txt   6707550

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE pstv-20250807_lab.xml EX-101.LAB 2719
3 INLINE XBRL TAXONOMY EXTENSION - SCHEMA pstv-20250807.xsd EX-101.SCH 2891
27 EXTRACTED XBRL INSTANCE DOCUMENT ny20044912x1_pre14a_htm.xml XML 178876
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34375 | Film No.: 251119077
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)